Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

DexCom, Inc. DXCM

Healthcare  —  Medical Devices
86.62 (0.85) (0.97%) as of 25 Sep
Market cap
$33.0B
P/E
33.4×
S&P 500 Member Cash Flow Champion (3y) Revenue Champion (10y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

DexCom, Inc. (DXCM) P/S ratio

As of 25 September 2026, DexCom, Inc. (DXCM) trades at a P/S ratio of 6.7×. Over the past ten years it has ranged from 4.6× (April 2026) to 27.2× (November 2021); the current reading is higher than 10% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 5.6× (26.81%)
FY2024 7.6× (42.13%)
FY2023 13.1× (14.57%)
FY2022 15.4× (27.62%)
FY2021 21.2× 17.13%
FY2020 18.1× 34.13%
FY2019 13.5× 31.82%
FY2018 10.2× 47.03%
FY2017 7.0× (17.97%)
FY2016 8.5× (47.77%)

Quarterly

Period P/S ratio Change
Jun 2026 5.2× 3.20%
Mar 2026 5.0× (9.64%)
Dec 2025 5.6× (4.68%)
Sep 2025 5.8× (26.77%)
42 more quarters

Against its own ten years

Low 4.6× High 27.2×
Ten-year median 12.6×
Current reading's percentile 10

P/S ratio against peers

Company P/S ratio
SNN Smith & Nephew SNATS, Inc. compare 1.2×
PHG Koninklijke Philips N.V. compare 1.2×
GEHC GE HealthCare Technologies Inc. compare 1.4×
ZBH Zimmer Biomet Holdings, Inc. compare 2.1×
BSX Boston Scientific Corporation compare 3.1×
STE STERIS plc compare 3.4×
DXCM DexCom, Inc. 6.7×
EW Edwards Lifesciences Corporation compare 7.6×
PEN Penumbra, Inc. compare 8.3×
Medical Devices industry median 2.7×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on DXCM